TRIGR (Trial to Reduce IDDM in the Genetically at Risk) is an international, randomized, double-blinded trial. The hypothesis to be tested is whether hydrolyzed infant formula compared to cow's milk-based formula decreases risk of developing type 1 diabetes in children with increased genetic susceptibility. Recruitment is completed; no more babies will be enrolled.
Ancillary Studies information now available. Learn More >
TRIGR Parents: Click here for the Asthma and Allergy Study Survey: Asthma Study Survey >
Click here for the Follow Up Study: TRIGR Follow Up Study >
For more information about this study in your country, please click on your flag:
TRIGR is Sponsored By:
Study Formula Provided By: